In 2022, the European Peripheral Vascular Devices Market was valued at around €1.5 billion, and it is projected to grow at a CAGR of 3.1% during the forecast period. As a result, it is anticipated to reach approximately €1.9 billion. Throughout this medical device market research, we analyzed over 50 companies within the peripheral vascular

The full report suite on the U.S. market for peripheral vascular devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters.

Carotid stenting can be accompanied with plaque dislodgment and plaque emboli. Thus, the initial popularity of carotid stents were tainted as these artifacts caused an unacceptably high incidence rate of strokes. Since then, the industry has responded by manufacturing embolic protection devices (EPDs). These devices are used to capture dislodged vascular debris.
There are many different EPD platforms available for use in the peripheral vascular market, including filters, arterial occlusion balloons and devices that redirect blood flow.